Acyclic nucleoside phosphonates: A study on cytochrome P450 gene expression

Jana Nekvindova, Juan Antonio Contreras, Peter Juvan, Klementina Fon Tacer, Pavel Anzenbacher, Zdenek Zidek, Michaela Kopecna Zapletalova, Damjana Rozman, Eva Anzenbacherova

Research output: Contribution to journalArticle

Abstract

1. Nucleotide analogues comprise an important class of drugs used in treatment of viral infections but also cancer. These drugs affect the structural integrity of DNA and activate different pathways and processes in the cell and may directly or indirectly influence the drug metabolizing system. Adefovir dipivoxil (AD) and tenofovir disoproxil (TD) are nucleotide analogues approved for the treatment of chronic hepatitis B and/or HIV/AIDS infection. 2. To evaluate the risk of their drug-drug interactions on the level of drug metabolism, an effect of both compounds on cytochromes P450 expression was studied using cDNA microarrays, real-time RT-PCR and immunoblotting. Mice were given intraperitoneally 25 mg/kg of AD or TD, respectively. As a positive control, a combination of prototypic cytochromes P450 (CYP) inducers, phenobarbital and β-naphthoflavone was chosen. 3. The data obtained showed a significant CYP induction in the positive control group, but no clinically significant induction of CYP genes by AD or TD was observed. Our results support the evidence of safety of AD and TD with respect to drug-drug interactions based on enzyme induction. These findings are important as a plethora of new antivirals of different types are being tested and introduced to clinical practice, mostly to be used in combinations.

Original languageEnglish (US)
Pages (from-to)708-715
Number of pages8
JournalXenobiotica
Volume44
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Tenofovir
Organophosphonates
Nucleosides
Gene expression
Cytochrome P-450 Enzyme System
Gene Expression
Drug interactions
Pharmaceutical Preparations
Drug Interactions
Nucleotides
Enzyme Induction
Chronic Hepatitis B
Virus Diseases
Phenobarbital
Oligonucleotide Array Sequence Analysis
Immunoblotting
HIV Infections
Antiviral Agents
Structural integrity
Microarrays

Keywords

  • Adefovir
  • Antiviral
  • CYP
  • Drug metabolism
  • Induction
  • PMEA
  • PMPA
  • Tenofovir

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Pharmacology
  • Toxicology
  • Biochemistry
  • Medicine(all)

Cite this

Nekvindova, J., Contreras, J. A., Juvan, P., Fon Tacer, K., Anzenbacher, P., Zidek, Z., ... Anzenbacherova, E. (2014). Acyclic nucleoside phosphonates: A study on cytochrome P450 gene expression. Xenobiotica, 44(8), 708-715. https://doi.org/10.3109/00498254.2014.895880

Acyclic nucleoside phosphonates : A study on cytochrome P450 gene expression. / Nekvindova, Jana; Contreras, Juan Antonio; Juvan, Peter; Fon Tacer, Klementina; Anzenbacher, Pavel; Zidek, Zdenek; Kopecna Zapletalova, Michaela; Rozman, Damjana; Anzenbacherova, Eva.

In: Xenobiotica, Vol. 44, No. 8, 2014, p. 708-715.

Research output: Contribution to journalArticle

Nekvindova, J, Contreras, JA, Juvan, P, Fon Tacer, K, Anzenbacher, P, Zidek, Z, Kopecna Zapletalova, M, Rozman, D & Anzenbacherova, E 2014, 'Acyclic nucleoside phosphonates: A study on cytochrome P450 gene expression', Xenobiotica, vol. 44, no. 8, pp. 708-715. https://doi.org/10.3109/00498254.2014.895880
Nekvindova J, Contreras JA, Juvan P, Fon Tacer K, Anzenbacher P, Zidek Z et al. Acyclic nucleoside phosphonates: A study on cytochrome P450 gene expression. Xenobiotica. 2014;44(8):708-715. https://doi.org/10.3109/00498254.2014.895880
Nekvindova, Jana ; Contreras, Juan Antonio ; Juvan, Peter ; Fon Tacer, Klementina ; Anzenbacher, Pavel ; Zidek, Zdenek ; Kopecna Zapletalova, Michaela ; Rozman, Damjana ; Anzenbacherova, Eva. / Acyclic nucleoside phosphonates : A study on cytochrome P450 gene expression. In: Xenobiotica. 2014 ; Vol. 44, No. 8. pp. 708-715.
@article{522837958a044af598069c0d6beb4362,
title = "Acyclic nucleoside phosphonates: A study on cytochrome P450 gene expression",
abstract = "1. Nucleotide analogues comprise an important class of drugs used in treatment of viral infections but also cancer. These drugs affect the structural integrity of DNA and activate different pathways and processes in the cell and may directly or indirectly influence the drug metabolizing system. Adefovir dipivoxil (AD) and tenofovir disoproxil (TD) are nucleotide analogues approved for the treatment of chronic hepatitis B and/or HIV/AIDS infection. 2. To evaluate the risk of their drug-drug interactions on the level of drug metabolism, an effect of both compounds on cytochromes P450 expression was studied using cDNA microarrays, real-time RT-PCR and immunoblotting. Mice were given intraperitoneally 25 mg/kg of AD or TD, respectively. As a positive control, a combination of prototypic cytochromes P450 (CYP) inducers, phenobarbital and β-naphthoflavone was chosen. 3. The data obtained showed a significant CYP induction in the positive control group, but no clinically significant induction of CYP genes by AD or TD was observed. Our results support the evidence of safety of AD and TD with respect to drug-drug interactions based on enzyme induction. These findings are important as a plethora of new antivirals of different types are being tested and introduced to clinical practice, mostly to be used in combinations.",
keywords = "Adefovir, Antiviral, CYP, Drug metabolism, Induction, PMEA, PMPA, Tenofovir",
author = "Jana Nekvindova and Contreras, {Juan Antonio} and Peter Juvan and {Fon Tacer}, Klementina and Pavel Anzenbacher and Zdenek Zidek and {Kopecna Zapletalova}, Michaela and Damjana Rozman and Eva Anzenbacherova",
year = "2014",
doi = "10.3109/00498254.2014.895880",
language = "English (US)",
volume = "44",
pages = "708--715",
journal = "Xenobiotica",
issn = "0049-8254",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Acyclic nucleoside phosphonates

T2 - A study on cytochrome P450 gene expression

AU - Nekvindova, Jana

AU - Contreras, Juan Antonio

AU - Juvan, Peter

AU - Fon Tacer, Klementina

AU - Anzenbacher, Pavel

AU - Zidek, Zdenek

AU - Kopecna Zapletalova, Michaela

AU - Rozman, Damjana

AU - Anzenbacherova, Eva

PY - 2014

Y1 - 2014

N2 - 1. Nucleotide analogues comprise an important class of drugs used in treatment of viral infections but also cancer. These drugs affect the structural integrity of DNA and activate different pathways and processes in the cell and may directly or indirectly influence the drug metabolizing system. Adefovir dipivoxil (AD) and tenofovir disoproxil (TD) are nucleotide analogues approved for the treatment of chronic hepatitis B and/or HIV/AIDS infection. 2. To evaluate the risk of their drug-drug interactions on the level of drug metabolism, an effect of both compounds on cytochromes P450 expression was studied using cDNA microarrays, real-time RT-PCR and immunoblotting. Mice were given intraperitoneally 25 mg/kg of AD or TD, respectively. As a positive control, a combination of prototypic cytochromes P450 (CYP) inducers, phenobarbital and β-naphthoflavone was chosen. 3. The data obtained showed a significant CYP induction in the positive control group, but no clinically significant induction of CYP genes by AD or TD was observed. Our results support the evidence of safety of AD and TD with respect to drug-drug interactions based on enzyme induction. These findings are important as a plethora of new antivirals of different types are being tested and introduced to clinical practice, mostly to be used in combinations.

AB - 1. Nucleotide analogues comprise an important class of drugs used in treatment of viral infections but also cancer. These drugs affect the structural integrity of DNA and activate different pathways and processes in the cell and may directly or indirectly influence the drug metabolizing system. Adefovir dipivoxil (AD) and tenofovir disoproxil (TD) are nucleotide analogues approved for the treatment of chronic hepatitis B and/or HIV/AIDS infection. 2. To evaluate the risk of their drug-drug interactions on the level of drug metabolism, an effect of both compounds on cytochromes P450 expression was studied using cDNA microarrays, real-time RT-PCR and immunoblotting. Mice were given intraperitoneally 25 mg/kg of AD or TD, respectively. As a positive control, a combination of prototypic cytochromes P450 (CYP) inducers, phenobarbital and β-naphthoflavone was chosen. 3. The data obtained showed a significant CYP induction in the positive control group, but no clinically significant induction of CYP genes by AD or TD was observed. Our results support the evidence of safety of AD and TD with respect to drug-drug interactions based on enzyme induction. These findings are important as a plethora of new antivirals of different types are being tested and introduced to clinical practice, mostly to be used in combinations.

KW - Adefovir

KW - Antiviral

KW - CYP

KW - Drug metabolism

KW - Induction

KW - PMEA

KW - PMPA

KW - Tenofovir

UR - http://www.scopus.com/inward/record.url?scp=84904001275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904001275&partnerID=8YFLogxK

U2 - 10.3109/00498254.2014.895880

DO - 10.3109/00498254.2014.895880

M3 - Article

C2 - 24593268

AN - SCOPUS:84904001275

VL - 44

SP - 708

EP - 715

JO - Xenobiotica

JF - Xenobiotica

SN - 0049-8254

IS - 8

ER -